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Abstract  
Objective: Mood instability (MI) is common in the general population. Mood instability is a 
precursor to mental illness and associated with a range of negative health outcomes. Sleep 
disturbance appears to be closely linked with MI. This study assesses the association between 
MI and sleep disturbance and the link with suicidal ideation and behaviour in a general 
population sample in England.   
Method: The Adult Psychiatric Morbidity Survey 2007 collected detailed information about 
mental health symptoms and correlates in a representative sample of adult household 
residents living in England (n=7303). Mood instability was assessed using the Structured 
Clinical Interview for DSM IV Axis II. Sleep problems were defined as sleeping more than 
usual or less than usual during the past month. Other dependent variables included 
medication use and suicidal ideation and behaviour (response rate 57%). Generalized linear 
modelling was used to estimate the prevalence of MI and sleep problems. Logistic regression 
was used to estimate odds ratios. All estimates were weighted. 
Results: The prevalence of MI was 14.7% (95% CI 13.6%-15.7%). Sleep problems occurred 
in 69.8% (95% CI 66.6%-73.1%) of those with MI versus 37.6% (95% CI 36.2%-39.1%) of 
those without MI. The use of sedating and non-sedating medications did not influence the 
association. Sleep problems were significantly associated with suicidal ideation and 
behaviour even after adjusting for MI. 
Conclusion: Sleep problems are highly prevalent in the general population, particularly 
among those with MI. Sleep problems are strongly associated with suicidal ideation and 
behaviour. Treatments that target risk and maintenance factors that transcend diagnostic 
boundaries, such as therapies that target sleep disturbance, may be particularly valuable for 
preventing and addressing complications related to MI such as suicide. 
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Introduction 
Mood instability (MI) is a poorly understood, but common mental health problem in 
the general population (Marwaha et al., 2013b). MI is a risk factor for suicidal behavior in the 
general population (Marwaha et al., 2013a). It has been linked with a number of psychiatric 
conditions such as mood, personality, and anxiety disorders (Patel et al., 2015; Marwaha et 
al., 2014). Although commonly a symptom of psychiatric disorders, it can occur independent 
of and may be a precursor to mental illness. Given the significance of MI in 
psychopathology, it is important to understand its nature and correlates 
Sleep may play a key role in affective regulation. Mood changes are often preceded 
by and co-occurring with sleep disturbance (Bauer et al., 2008) and poor sleep may 
contribute to or worsen MI (Bowen et al., 2013). In bipolar disorder, sleep disturbance has 
been identified as the most robust prodrome of mania (Jackson et al., 2003) and has been 
associated with more severe course of illness including recurrence of major mood episodes, 
history of psychosis, and number of suicide attempts (Sylvia et al., 2012). In unipolar 
depression, sleep appears to be a mediator of the association between MI and depression 
(Marwaha et al., 2015). It is unclear to what extent this association is limited to diagnosed 
psychiatric disorder or whether it is a more pervasive pattern observed in the population more 
generally.  
A major advantage of population surveys is that they are capable of capturing a 
representative sample of the population. Clinical investigations and administrative data 
represent only individuals who have been in contact with health services and therefore miss a 
large portion of the population. Studying MI in this type of survey allows a unique 
opportunity to examine individuals who may have subsyndromal mood symptoms or who are 
at risk for future clinical illness and to identify potential transdiagnostic processes. 
The aim of this study was to examine the association between sleep problems and MI 
and the link with suicidal ideation and behaviour in a general population sample. We 
hypothesized that (a) sleep problems are positively associated with MI (b) individuals with 
MI who are using psychotropic medications who have MI are less likely to have sleep 
problems than individuals with MI not taking psychotropic medication; and (c) sleep 
problems are positively associated with suicidal behaviour, particularly in those with MI. To 
our knowledge, this is the first study to examine MI and sleep disturbance in a general 
population sample.  
  
Method 
Adult Psychiatric Morbidity Survey 2007  
Data were from phase one of the Adult Psychiatric Morbidity Survey 2007 (APMS 
2007), a cross-sectional survey of sociodemographic features, mental health, and morbidity 
and correlates in adults age 16 and older living in private households in England. Data were 
collected via multi-stage stratified random sampling between October 2006 and December 
2007. Interviews were completed in person by trained lay interviewers. Details of the survey 
have been published elsewhere (National Centre for Social Research, 2011; Bebbington et al., 
2009). The overall response rate for phase one of the survey was 57%, for a final sample size 
of 7403 respondents. Data are available from the UK Data Archive; further information is 
available online (http://www.hscic.gov.uk/pubs/psychiatricmorbidity07). The Royal Free 
Hospital and Medical School Research Ethics Committee provided ethical approval for 
APMS 2007. 
Measures 
MI was measured using a single item from the borderline module of the Structured 
Clinical Interview for DSM IV-II (SCID-II): “Do you often have a lot of sudden mood 
changes?” (First et al., 1997). This item was answered by all respondents.  
Self-reported sleep problems included (a) sleeping less than usual, “In the past month, 
have you been having problems with trying to get to sleep or with getting back to sleep if you 
woke up or were woken up?”; and (b) sleeping more than usual, “Has sleeping more than you 
usually been a problem for you in the past month?”. For the purpose of this study, any sleep 
problem includes all respondents who experienced sleeping more than usual or sleeping less 
than usual.  
Income represents equivalised annual household income (total household income 
divided by a score computed based on the number, age, and relationships of household 
members). Body mass index (BMI) was calculated from self-reported height and weight of 
the respondent. Prescribed medications were self-reported and verified by the interviewer by 
examining the medication packages, and included commonly prescribed medications 
(antipsychotics, antidepressants, sedative-hypnotics, and lithium) for psychiatric symptoms. 
We then grouped medications by those with high risk of sedation (sedating) and medications 
with low risk of sedating effects (non-sedating). The Alcohol Use Disorders Identification 
Test (AUDIT) is a 10-item screening test designed to assess patterns of alcohol consumption. 
Higher scores indicate more hazardous drinking patterns (Saunders et al., 1993). Alcohol and 
substance dependence were measured using questions based on the diagnostic interview 
schedule (DIS; Compton and Cottler, 2004). 
Statistical Analysis 
Demographic features were described as frequencies and percents. Prevalence of 
mood instability and sleep problems were estimated using generalized linear modeling of the 
binomial family with a log link function. To examine if having any sleep problem was 
associated with MI independently or if it was influenced by psychiatric disorder, we 
calculated the odds ratio (OR) of any sleep problem in those with MI and psychiatric 
condition, with MI and no psychiatric condition, and psychiatric condition without MI 
against the reference group without MI or a psychiatric condition. Using the same reference 
group allows direct comparison of the relative influence of MI and psychiatric diagnosis on 
the association with sleep problems. We also explored the influence of taking psychotropic 
medications on the association between sleep problems and MI. We compared models 
including any medication, sedating medications, and non-sedating medications to crude 
models. Finally, we explored the association between sleep problems and suicide in those 
with and without any sleep problem. ORs were calculated using logistic regression. Analyses 
were assessed for age and sex interactions and confounding, including the possible influence 
of quadratic age trends. Potential modifiers of the association were determined using Wald 
tests. The presence of a potential confounder was assessed by comparing the adjusted and 
crude estimates, if the two estimates were meaningfully different, the variable was considered 
a confounder. All statistical tests used a 5% significance level.  
Since a multi-phase stratified sampling design was used, all analyses were weighted 
using the svy commands (using Taylor linearized variance and scaled variance for singleton 
strata) in order to produce corrected variance estimates and results that are more 
representative of the target population. Analyses were carried out in Stata version 11 
(StataCorp, 2009). 
Results 
The weighted sample size was 7393. All sample sizes and statistics presented in this 
paper are weighted and sample sizes are rounded to the nearest whole number. Proportions of 
missing data for each major subgroup (MI, professionally diagnosed psychiatric condition, 
any sleep problem) were less than 1%. 
Demographic features and selected covariates of sleep problems in the subsamples are 
shown in table 1. Those who were female, single, employed part-time, and those with a  
lower income more frequently reported MI. MI was also very common among those with 
alcohol or substance use problems.  
Table 1. Frequencies and percents of those with mood instability (n=1073) and sleep 
problems (n=3299) reporting levels of selected demographic features and possible covariates. 
 
 
Mood Instability Sleep Problems 
 n1 % n1 % 
Age (years)     
16-34 504 22.5 906 39.9 
35-54 393 15.1 1084 41.3 
55+ 176 7.1 1142 45.6 
Sex      
Male 409 11.5 1256 35.0 
Female 664 17.6 1875 49.3 
Ethnicity      
White 958 14.5 2798 42.2 
Black 33 14.9 95 42.4 
South Asian 42 15.7 111 39.0 
Other 34 16.1 102 47.6 
Marital Status      
Single 387 23.2 700 41.7 
Widowed/ Divorced/ 
Separated 
136 12.9 529 49.6 
Married/ Cohabitating 551 12.0 1903 40.9 
Employment      
Full-time 411 14.9 1564 42.0 
Part-time 198 18.0 638 34.9 
Not employed 459 13.2 1564 49.8 
Income2      
< £10,575 240 22.2 570 52.4 
≥ £10,575 - < £16,195 130 13.1 455 45.7 
≥ £16,195 - < £24,700 152 13.3 487 42.4 
≥ £24,700 - < £40,384 126 10.9 419 36.2 
≥ £40,384 135 10.9 478 38.3 
Body mass index      
<18.5 kg/m2 46 26.8 88 50.7 
18.5 to <25 kg/m2 461 14.6 1322 41.4 
25 to <30 kg/m2 287 12.0 985 40.6 
≥ 30 kg/m2 207 16.8 570 45.9 
Psychotropic medications      
Any medication 179 41.2 318 72.3 
Antipsychotic 25 54.6 32 67.9 
Antidepressant 146 42.2 253 72.9 
Sedative-hypnotic 39 42.7 71 76.3 
Lithium 6 41.6 7 64.9 
Audit      
0-7 712 12.8 2345 41.9 
8-15 260 17.3 641 42.6 
16-40 102 37.1 135 51.4 
Alcohol dependence, % yes 167 38.7 247 56.9 
Substance dependence, % 
yes 
108 42.8 142 56.3 
1 Weighted sample size, rounded to the nearest whole number; 2Equivalised annual 
household income 
The estimated lifetime prevalence of MI was 14.7% (95% CI 13.6%-15.7%). 
Estimated prevalence was significantly higher in females (17.6%, 95% CI 16.1%-19.1%) 
compared with males (11.5%, 95% CI 10.1%-12.9%) and decreased approximately linearly 
with age (by about 1% prevalence per year of age) for both sexes. 
Among those with MI, approximately 69.8% (95% CI 66.6%-73.2%) reported 
sleeping more or sleeping less than usual, considerable higher than 37.6% (95% CI 36.2%-
39.1%) of those without MI. 
The estimated odds of having any sleep problem in those with MI versus those 
without MI depended on gender. In males, the association between having a sleep problem 
and MI was modified by quadratic age. After accounting for quadratic age, there was no 
significant association between sleep problems and MI in males. Neither quadratic age nor 
linear age terms modified or confounded the relationship among females. In females, the 
odds of having a sleep problem were significantly higher in those with MI than in those 
without MI (OR=2.8, 95% CI 2.3-3.6).  
Compared with the reference group (having no diagnosed psychiatric condition or 
MI), the OR of any sleep problem for those with both MI and a diagnosis was highest, 
followed by MI without a diagnosis, then a diagnosis without MI (table 2). Similar trends 
were observed for both genders, however, the strength of relationship in males appeared 
stronger at all levels. Odds ratio did not depend on age for these subgroups.  
Table 2. Estimated odds ratios of having a sleep problem comparing three mood instability 




OR1 95% CI OR1 95% CI 
Diagnosis with MI2 11.6 6.7-19.9 3.8 2.8-5.1 
No Diagnosis with MI2 4.2 3.1-5.8 2.9 2.2-3.8 
Diagnosis without MI2 2.3 1.7-3.1 1.9 1.6-2.3 




1 OR = odds ratio; 2 MI = mood instability; 3 Reference group 
Sleeping less than usual and sleeping more than usual were significantly associated 
with MI. The association between sleeping less than usual and MI was stronger in males 
(OR=4.2, 95% CI 3.2-5.4) than females (OR=2.6, 95% CI 2.1-3.2). The OR of sleeping more 
than usual was similar for both males and females (OR=4.5, 95% CI 3.1-6.6). Age did not 
influence the estimate of association for either sleeping more or sleeping less than usual.  
We assessed the influence of taking sedating and non-sedating medicatinos on the 
estimated OR of having a sleep problem in those with MI versus those without. We observed 
no influence of taking either sedating or non-sedating medication for any of any sleep 
problem, sleeping more or sleeping less than usual. 
The prevalence of suicide ideation in the total sample was 0.81% (95% CI 0.6%-
1.0%) during the past week, 4.3% (95% CI 3.7%-4.9%) during the past year, and 13.7% 
(95% CI 12.8%-14.7%) during the lifetime. The prevalence of suicide attempt was 0.7% 
(95% CI 0.4%-0.9%) during the past year, and 4.8% (95% CI 4.2%-5.4%) during the lifetime 
(there was only n=1 suicide attempt during the past week). 
Estimates of the association between any sleep problem and suicidal ideation or 
behavior are presented in table 3.  MI, age, and sex were assessed to determine if their 
inclusion in the model significantly changed the estimate of association using a combination 
of forward and backward selection. The relationship between sleep and suicidal ideation or 
behavior did not appear to be influenced by age or sex and was not modified by the presence 
of MI. However, adjusting for mood did appear to diminish the strength of the association. 
Estimates for past week suicide attempt were unavailable owing to insufficient sample size. 
Table 3. Estimated odds ratios of suicide ideation or attempt among individuals with any 
sleep problem versus no sleep problem.  
 Unadjusted OR1 (95% CI) Adjusted OR1-2 (95% CI)1 
Suicide 
ideation 
    
Past week 8.0 3.6-17.8 5.0 2.1-11.8 
Past year 5.0 3.6-6.8 3.1 2.2-4.3 
Lifetime 3.1 2.6-3.7 2.2 1.8-2.7 
Suicide 
attempt 
    
Past week3     
Past year 2.5 1.2-5.2 1.1 0.4-2.6 
Lifetime 3.2 2.4-4.3 2.1 1.5-2.8 
1 OR = Odds ratio; 2 Adjusted for mood instability; 3 Estimates unavailable owing to 
insufficient sample sizes 
Discussion 
The lifetime prevalence of MI in this study was approximately 14.7%. A previous 
study using the same data (Marwaha et al., 2014) observed a prevalence of 13.9%. This 
discrepancy is the result of differing methods of analysis; the prevalence estimate from the 
present study has been weighted, while the estimate made previously was unweighted. 
Weights are applied in order to account for non-response and to produce results that are more 
representative of the target population. Owing to the complex survey design, individuals have 
unequal selection probabilities and weights are applied to address potential resulting bias. 
Given that our analyses included weights, it is likely that our estimate is more representative 
of the true population prevalence of MI.  
We observed that MI was significantly and positively associated with having sleep 
problems among females, but not males. This is an important finding because sleep problems 
have been associated with a range of negative health consequences including decreased 
quality of life (Ohayon et al., 2013), cardiovascular outcomes (Cappuccio et al., 2011), 
inflammation (Motivala and Irwin, 2007), diabetes (Gottlieb et al., 2005), and early mortality 
(Ferrie et al., 2007). 
Importantly, we observed that the association with having a sleep problem appeared 
to be strongest when MI was present, especially if also diagnosed with a psychiatric 
condition. This may suggest that sleep disturbance is more strongly associated with the 
presence of MI than a psychiatric condition. However, these findings are limited owing to the 
cross-sectional data and because the measure of psychiatric condition includes all individuals 
who have ever been diagnosed with a mental illness and may not have symptoms of the 
condition at present.  
Finally, we observed that having any sleep problem was significantly and positively 
association with suicidal ideation and attempt for all measured time periods. This finding is 
consistent with prior research, which shows evidence that sleep problems such as insomnia, 
nightmares, and other sleep disorders increase the risk of suicidal ideation and 
behaviour.(Pigeon et al., 2012; Bernert et al., 2015) Adjusting for MI diminished the strength 
of association, particularly for past week and past year suicidal ideation; the unadjusted odds 
of suicidal ideation during the past week were approximately 8-fold higher in those with 
sleep problems versus those without, and still nearly 5-fold after adjusting for MI.  
Identifying modifiable risk factors associated with the development and maintenance 
of multiple different pathologies is relevant for guiding clinical interventions and preventing 
and diminishing morbidity and mortality. Sleep disturbance may be a modifiable and 
transdiagnostic risk factor for psychiatric morbidity (Harvey et al., 2011; Harvey, 2008). 
Individuals reporting MI may be showing prodromal or subsyndromal symptoms. Effectively 
treating early symptoms of illness is critical for prevention or improving disease course. 
Preliminary evidence shows that maintaining sleep reduces MI (Bowen et al., 2013). 
Therapies that address transdiagnostic factors such as sleep therapies may be effective, 
particularly given that psychiatric illnesses that are often complex, multifactorial, and 
commonly comorbid. Although these cross-sectional data cannot reveal causality, the results 
also suggest that addressing current sleep problems may be particularly valuable for 
ameliorating immediate suicidal thoughts or behaviours. Future research should aim to 
investigate the link between MI and development of psychiatric disorders and the potential 
role of sleep-related therapies. 
Limitations 
We recognize a few limitations to this study. First, the measure of MI in the survey 
relies on a single, subjective question about the frequency of mood changes. While there is no 
clear and consistently used definition of MI, existing definitions typically involve aspects of 
lability, intensity, and proportionality to social situations in addition to frequency of mood 
changes (Marwaha et al., 2014). The question in this survey only involves one of several 
aspects of mood instability and it is based on the SCID-II, which is founded in the DSM-IV 
(American Psychiatric Association, 2000) diagnosis of borderline personality disorder. 
Although the question has been thoroughly validated in borderline personality disorder, the 
phenomenological meaning of a positive answer is less clear in other groups. Additionally, 
the cross-sectional nature of the study provides no indication of temporality of the 
association. Both MI and sleep problems were self-report and not assessed prospectively. 
Sleep problems may represent a symptom of MI, but poor sleep quality appears to also 
produce or exacerbate MI (Bowen et al., 2013). In bipolar disorder, the association appears to 
be bidirectional (Talbot et al., 2012). While the results of this study represents a cautious 
estimate of MI, it is useful for generating future hypotheses and guiding possibly meaningful 
future research avenues.  
Finally, the role of medication in the relation between sleep and MI warrants more 
systematic investigation. In this study, accounting for the use of sedating and non-sedating 
medication in the analysis did not appear to alter the estimate of association. However, many 
psychotropic medications such as antidepressants and antipsychotics have sometimes 
profound effects on sleep (e.g. Winokur et al., 2001 for review).  It is possible that our 
classifications of medications were too broad, thereby limiting the ability to disentangle the 
association. We were unable to narrow the classes owing to insufficient power. Narrowing 
the classes to include only medications with more specific sleep effects may improve control. 
Additionally, many other medicines commonly prescribed to treat psychiatric symptoms such 
as antipeileptics were not assessed in this survey. It is likely that the influence of medication 
on the association between sleep disturbance and mood instability is underestimated in our 
findings. 
Conclusion 
Sleep problems are very common in the general population and in those with MI. 
Suicidal ideation and behavior are higher in those with current sleep problems, even in the 
absence of MI. Given the apparently strong association between MI and sleep problems in the 
community, future work should examine this association more rigorously. Improved 
measures of MI including high frequency prospective mood monitoring (e.g. True Colours; 
www.truecolours.nhs.uk) have been developed. Future studies using objective, prospective 
designs may be worthwhile in elucidating the temporality between MI and sleep changes. 
Future research should also aim to systematically examine smaller classes of psychotropic 
medications in order to elucidate the effect of psychotropic medications. Finally, sleep 
problems are a potentially salient therapeutic target for reducing morbidity and mortality in 
the general population, particularly for those with MI. Treatments that target risk and 
maintenance factors that transcend diagnostic boundaries, such as therapies that target sleep 
disturbance, may be particularly valuable for preventing and addressing complications related 
to MI such as suicide. 
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